Questions remain about COVID-19 infection, transmission, treatment and recovery. Here are answers to some common questions about the coronavirus pandemic.
More countries on the African continent must urgently get involved in clinical trials so that the data collected will accurately represent the continent at a genetic level.
This fifth weekly column by our team of international health editors highlights more of the recently published articles from The Conversation’s global network.
The CDC now recommends that everyone wear a face covering when they go into a public place. But there’s confusion about why and if this protects the wearer, people around them or both.
Doctors are being forced to make difficult choices regarding who gets ventilators in this pandemic. An expert argues why this has parallels with choices soldiers have to make during wartime.
The SARS-CoV-2 virus that causes COVID-19 is constantly mutating. What do these mutations reveal about this virus’s evolution? And will this knowledge help us to develop a long-lasting vaccine?
The head lice drug Ivermectin has stopped SARS-CoV-2, the virus that causes COVID-19, from replicating in lab tests. But we don’t know if it will work as a treatment for people with coronavirus.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand